Efficacy and Safety of Brolucizumab for Diabetic Macular Edema

This randomized clinical trial evaluates the efficacy and safety of brolucizumab vs aflibercept dosed every 4 weeks in participants with diabetic macular edema.
Source: JAMA Ophthalmology - Category: Opthalmology Source Type: research